MDGN-205

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameMDGN-205
Drug Alias NameTARGTGLP-2™
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAevi Genomic Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvalo Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsShort Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A